%0 Journal Article
%A Gross, Neil D
%A Miller, David M
%A Khushalani, Nikhil I
%A Divi, Vasu
%A Ruiz, Emily S
%A Lipson, Evan J
%A Meier, Friedegund
%A Su, Yungpo Bernard
%A Swiecicki, Paul L
%A Atlas, Jennifer
%A Geiger, Jessica L
%A Hauschild, Axel
%A Choe, Jennifer H
%A Hughes, Brett G M
%A Schadendorf, Dirk
%A Patel, Vishal A
%A Homsi, Jade
%A Taube, Janis M
%A Lim, Annette M
%A Ferrarotto, Renata
%A Yoo, Suk-Young
%A Mathias, Melissa
%A Han, Hyunsil
%A Seebach, Frank
%A Lowy, Israel
%A Fury, Matthew G
%A Rischin, Danny
%T Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
%J The lancet / Oncology
%V 24
%N 11
%@ 1470-2045
%C London
%I The Lancet Publ. Group
%M DKFZ-2023-02161
%P 1196-1205
%D 2023
%Z 2023 Nov;24(11):1196-1205
%X We previously reported rates of pathological complete responses (51
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37875144
%R 10.1016/S1470-2045(23)00459-X
%U https://inrepo02.dkfz.de/record/284972